Pro Nephro AKI (NGAL) is now FDA-Cleared     READ MORE

Presentations

Q3 2024 Interim Report

November 14, 2024

Investor Presentation

October 22, 2024

Q2 2024 Interim Report

August 15, 2024

2024

2023

2022

2021

2020

2019